{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:16:39Z","timestamp":1738991799624,"version":"3.37.0"},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":10715,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1986,5]]},"DOI":"10.1111\/j.1600-0404.1986.tb04583.x","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T20:44:22Z","timestamp":1233261862000},"page":"449-457","source":"Crossref","is-referenced-by-count":18,"title":["Wernicke-Korsakoff-like syndrome in patients with colorectal carcinoma treated with high-dose doxifluridine (5\u2032-dFUrd)"],"prefix":"10.1155","volume":"73","author":[{"given":"M. S.","family":"Heier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. D.","family":"Foss\u00e5","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB1","first-page":"2683","article-title":"Chemotherapy of large bowel cancer","volume":"50","author":"Davis","year":"1982","journal-title":"Cancer."},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB2","first-page":"15","article-title":"Cerebellar ataxia associated with fluorinated pyrimidine therapy","volume":"41","author":"Moertel","year":"1964","journal-title":"Cancer Chemother Rep"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.14.10.961","article-title":"Acute cerebellar syndrome secondary to 5-fluorouracil therapy","volume":"14","author":"Riehl","year":"1964","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB4","first-page":"305","article-title":"Acute and chronic toxicity studies with 5-fluorouracil in man","volume":"2","author":"Hall","year":"1958","journal-title":"Proc Amer Assoc Cancer res"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB5","first-page":"459","article-title":"5-fluorouracil and allopurinol: toxicity modulation and Phase II results in colon cancer","volume":"22","author":"Kroener","year":"1981","journal-title":"Proc Am Ass Cancer Res (ASCA-abstr)"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0140-6736(71)90877-4","article-title":"Cerebellar ataxia with weekly 5-fluorouracil administrations","volume":"16","author":"Gottlieb","year":"1971","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB7","doi-asserted-by":"crossref","unstructured":"7. Weiss H D , Walker M D , Wiernick P H. Neurotoxicity of commonly used antineoplastic agents (First of two parts). New Engl J Med 1974 July:75-81.","DOI":"10.1056\/NEJM197407112910205"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB8","first-page":"3333","article-title":"Metabolism and biological activity of 5\u2032-deoxy-5-fluorouridine, a novel fluoropyrimidine","volume":"40","author":"Armstrong","year":"1980","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB9","first-page":"4891","article-title":"Selective activation of 5\u2032-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index","volume":"41","author":"Armstrong","year":"1981","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0014-2964(80)90221-2","article-title":"Tumor inhibitory effects of a new fluorouracil derivative: 5\u2032-deoxy-5-fluorouridine","volume":"16","author":"Bollag","year":"1980","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-3565(25)21961-9","article-title":"Pharmacokinetic studies of 5-fluorouracil and 5\u2032-deoxy-5-fluorouridine in rats","volume":"227","author":"Lai Sim","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB12","first-page":"2412","article-title":"Antiproliferative action of a novel fluorinated uridine analog, 5\u2032-deoxy-5-fluorouridine, measured in vitro and in vivo on four different murine tumor lines","volume":"42","author":"Hartmann","year":"1982","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB13","first-page":"1307","article-title":"Phase I clinical study with 5\u2032-deoxy-5-fluorouridine, a new fluoropyrimidine derivative","volume":"6","author":"Abele","year":"1982","journal-title":"Cancer Treat Rep"},{"issue":"3","key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0277-5379(84)90078-6","article-title":"Phase II study of doxyfluridine in advanced squamous cell carcinoma of the head and neck","volume":"20","author":"Abele","year":"1984","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"12","key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1200\/JCO.1983.1.12.750","article-title":"Phase II study of doxyfluridine in advanced colorectal adenocarcinoma","volume":"1","author":"Abele","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB16","unstructured":"16. Oosterom A T , Bokkel Huinink W W , Burg M L , Vriesendorp R , Boven E. Phase II study with 5\u2032-deoxy-5-fluorouridine (5-dFUR) in patients with advanced resistant ovarian cancer. 2nd Eur Conf Clin Oncol, Amsterdam 1983, Abstracts 05-31."},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB17","unstructured":"17. Hurteloup P , Metz R , Cappelaere P , et al. A Phase II trial of 5\u2032-deoxy-5-fluorouridine (5\u2032-dFUR) for advanced solid tumors. Preliminary results. 13 Int Cong Chemother, Vienna 1983, SE 12.1.20-10:259\/31-34."},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00257528","article-title":"Doxifluridine (5\u2032-dFUrd) in patients with advanced colorectal carcinoma","volume":"15","author":"Foss\u00e5","year":"1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0404.1985.tb00859.x","article-title":"Neurological manifestations in a Phase II study of 13 patients treated with doxyfluridine","volume":"72","author":"Heier","year":"1985","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB20","doi-asserted-by":"crossref","unstructured":"20. Foss\u00e5 S D , Flokkmann A , Heier M , Aas M , Moe B , Linder-Ciccolunghi S , Heintz R. Phase I tolerability\/pharmacokinetic study with 1-h intravenous infusion of doxifluiridine (5\u2032-dFUrd) 3 g\/m2 VS 5 g\/m2 QD x 5 per month. Cancer Chemother Pharmacol 1985 (submitted).","DOI":"10.1007\/BF00273397"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archneur.1970.00480260061008","article-title":"Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate","volume":"23","author":"Koenig","year":"1970","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1126\/science.164.3877.310","article-title":"Acute axonal dystrophy caused by fluorocitrate. The role of mitochondrial swelling","volume":"164","author":"Koenig","year":"1969","journal-title":"Science"},{"volume-title":"The Wernicke-Korsakoff syndrome","year":"1971","author":"Victor","key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB23"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB24","unstructured":"24. Lindboe C F , Seem E. Wernicke's encephalopathy in non-alcoholics (Eng. abstr.) Tidsskr Nor Laegeforen 1981:205-206."},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB25","first-page":"725","volume-title":"Wernicke-Korsakoff syndrome","author":"Brust","year":"1984"},{"key":"10.1111\/j.1600-0404.1986.tb04583.x-BIB26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF01888001","article-title":"\u00dcber die nichtalkoholishe Wernickesche Krankheit, Insbesondere \u00fcber ihr Vorkommen beim Krebsleiden","volume":"298","author":"Neub\u00fcrger","year":"1936","journal-title":"Wirchows Archiv (pathol. anat.)"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1986.tb04583.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1986.tb04583.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T08:57:56Z","timestamp":1738918676000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1986.tb04583.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1986,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1986.tb04583.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"type":"print","value":"0001-6314"},{"type":"electronic","value":"1600-0404"}],"subject":[],"published":{"date-parts":[[1986,5]]}}}